Skip to main content

UBS Group AG

Position in WGS — GeneDx Holdings Corp.

CIK 1610520 ZURICH, V8

Position in WGS

as of Jun 30, 2026 · filed Aug 13, 2026
Position Value
$14,324,714
+$11,060,734 QoQ
Shares Held
208,663
+310.6% QoQ
Ownership
0.700%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#26
of 223 holders
Holding Since
Mar 2021
18 quarters on record
Voting authority Sole 98% Shared 0% None 2%

Common Shares in WGS Over Time

Shares Held

Position Value (USD)

Derivatives in WGS

reported options exposure · as of Jun 30, 2025
CallValue
$0
CallShares
0
PutValue
$830,790
PutShares
9,000

Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.

Position in Diagnostics & Research

Healthcare · as of Jun 30, 2026

UBS Group AG holds $4,492,969,656 across 43 Diagnostics & Research names. WGS ranks #23 (0.3% of the industry book) .

# Ticker Company Shares Value (USD) Open

All Filings in WGS

Export CSV
19 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $14,324,714 208,663
2026-03-31 $3,263,980 50,825
2025-12-31 $11,600,049 89,190
2025-09-30 $16,138,265 149,789
2025-06-30 $92,468,772 1,001,720
2025-06-30 $830,790 9,000
2025-03-31 $4,617,866 52,141
2024-12-31 $3,605,116 46,905
2024-09-30 $569,374 13,416
2024-06-30 $235,024 8,991
2024-03-31 $3,423 375
2023-09-30 $698 192
2023-03-31 $81,559 223,452
2022-12-31 $24,197 91,659
2022-03-31 $52,616 17,139
2021-12-31 $81,790 18,339
2021-09-30 $191,647 25,250
2021-06-30 CMLF 5,236
2021-03-31 CMLF 2,004